サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1374798

ECGパッチとホルターモニターの世界市場-2023年～2030年

Global ECG Patches and Holter Monitor Market -2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 190 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ECGパッチとホルターモニターの世界市場-2023年～2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 190 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

外来モニタリング機器への動向、同分野の技術進歩、不整脈の早期発見のための投資の増加、テレメトリ分野の進歩が、予測期間中の市場の成長を後押しします。ECGパッチは、患者の心臓活動の電気信号を処理、取得、送信するために体表面（一般的には胸部）に接続される小型装置です。

モニターに表示された情報は、後に医療診断（ホルターモニター）やフィットネス活動における心拍数などのパラメータ表示に使用されます。ホルターモニター検査は、従来の心電図（ECGまたはEKG）では心臓の状態について十分な詳細が得られない場合に行われます。不整脈の頻度が少ない場合は、イベントレコーダーと呼ばれる長期モニターが必要になることもあります。

さらに、世界のECGは、不整脈の有病率の増加、主要企業による新しいデバイスの発売、企業との合併や買収、外来モニタリングデバイスの需要の増加、および技術の進歩は、Cardinal Health、Ambu、Hillrom（Baxter）、日本光電、Koninklijke Philips N.V.などの重要な主要企業を有する予測期間中に市場を牽引する可能性が高いです。

ダイナミクス

心房細動有病率の上昇

心房細動の有病率の増加は、予測期間中に市場が成長する重要な要因の1つです。有病率の増加は、ECGパッチとホルターモニターデバイスの高い需要につながります。

例えば、NCBIに掲載された最新の論文によると、心房細動は最も一般的に遭遇する心臓リズム障害です。心房細動の有病率は世界中で増加しています。心房細動の有病率は一般に年齢とともに増加することが知られています。心房細動の患者数は2050年までに2倍から3倍になると推定されています。

心房細動の世界の有病率は約1％であるが、75歳以上では約9％に認められます。80歳になると、心房細動の生涯発症リスクは22％に跳ね上がります。さらに、心房細動は男性に多く、黒人に比べて白人に多くみられます。

技術の進歩

技術的進歩の高まりは、予測期間中に市場が成長するための重要な要因の1つです。同市場における進歩の1つは、粘着式シングルリードデバイスがECG遠隔モニタリングの改善方法として過去20年にわたって台頭してきたことです。これらのバイオセンサー「パッチ」技術は、邪魔にならないデザインと最長14日間の装着時間により、心臓不整脈の診断においてホルターモニターを凌ぐことが示されています。iRhythm社のZIO（ジオ）は、不整脈の検出に使用される持続的外来モニタリングパッチ技術の一例です。また、ホルター技術でも数多くの技術が進化しており、この技術は予測期間中の市場の成長に貢献すると思われます。

例えば、2020年11月にバイタルコネクトは、心臓モニタリングのための世界初の拡張ホルター技術であるVitalPatch RTMの発売を発表しました。バイタルコネクトは、拡張ホルターモニタリングを必要とする患者向けに最新の心臓モニタリングパッチ、バイタルパッチRTMを発売しました。このウェアラブルバイオセンサーは、人工知能心電図センサーを使用して21種類の不整脈を検索します。心拍数、心拍変動、呼吸数、活動量の4つの重要なバイタルサインを継続的にモニターします。

面倒で時代遅れのホルター心電図解析

心臓専門医が手作業で行う従来のホルター心電図解析は複雑で、多大な労力を要します。ホルター検査を実施する場合、看護師がホルター装置から生信号をコンピュータにアップロードしなければならず、その後、医師が現在の知識と経験に基づいてレポートを作成します。従って、医師がこのような報告書を正しく作成するには、経験豊富で、正確で、用心深くなければならないです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 心房細動の有病率の上昇
      • 技術の進歩
    • 抑制要因
      • 面倒で時代遅れのホルター心電図分析
    • 機会
      • 新興市場での製品上市の増加
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 デバイスタイプ別

  • 心電図パッチ
  • ホルターモニター

第8章 アプリケーション別

  • モニタリング
  • 診断

第9章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Cardinal Health
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Ambu
  • Hillrom（Baxter）
  • Nihon Kohden
  • Koninklijke Philips N.V.
  • Koninklijke Philips N.V.
  • SCHILLER
  • GE Healthcare
  • Henry Schein
  • Spacelabs Healthcare

第13章 付録

目次
Product Code: MD7215

Overview

The trend towards ambulatory monitoring devices, technological advancements in the field, increase in investments for early detection of arrhythmia, and advancements in the field of telemetry will help the market to grow during the forecast period. The ECG patch is a small device that is connected to the body surface (commonly the chest) to process, acquire and transmit the electrical signal of the patient's heart activity.

The information which was shown in monitor is later used for medical diagnostics (Holter monitors) or for displaying parameters such as heart rate in fitness activities. A Holter monitor test may be done if a traditional electrocardiogram (ECG or EKG) doesn't provide enough details about the heart's condition. If the irregular heartbeats are infrequent, a longer-term monitor called an event recorder may be needed.

Furthermore, the global ECG The Growing prevalence of cardiac arrhythmia, new device launches by key players, mergers and acquisitions with the companies, increasing demand for ambulatory monitoring devices, and technological advancements are likely to drive the market during the forecast period with having significant key players like Cardinal Health, Ambu, Hillrom (Baxter), Nihon Kohden, Koninklijke Philips N.V and others.

Dynamics

Rise in the Prevalence of Atrial Fibrillation

The rise in the prevalence of atrial fibrillation is one of the key factors that help the market to grow during the forecast period. Increase the prevalence will lead to high demand for ECG Patches and Holter monitor devices.

For instance, according to an updated article published in NCBI Atrial fibrillation is the most commonly encountered cardiac rhythm disorder. The prevalence of atrial fibrillation has been increasing worldwide. It is known that the prevalence of atrial fibrillation generally increases with age. It has been estimated that the number of individuals with atrial fibrillation will double or triple by the year 2050.

Although the worldwide prevalence of atrial fibrillation is approximately 1%, it is found in approximately 9% of individuals over the age of 75. At the age of 80, the lifetime risk of developing atrial fibrillation jumps to 22%. In addition, atrial fibrillation has more commonly been associated with males and is seen more often in whites as compared to blacks.

Rise in the Technological Advancements

The rise in the technological advancements is one of the key factors that helps the market to grow during the forecast period. One of the advancements in this market was Adhesive single-lead devices have been emerging over the last 20 years as an improved method of ECG remote monitoring. With their less obtrusive design and wear time of up to 14 days, these biosensor 'patch' technologies have been shown to outperform Holter monitors in diagnosing cardiac arrhythmias. ZIO by iRhythm (Zio) is an example of a continuous ambulatory monitoring patch technology used to detect cardiac arrhythmias. Also, numerous technologies have been evolved in Holter Technology and this technology will help the market to grow during the forecast period.

For instance, in November 2020 Vital Connect announced the Launch of VitalPatch RTM, a first-of-its-kind extended holter technology for cardiac monitoring. Vital Connect has launched its latest cardiac monitoring patch, the VitalPatch RTM, for patients who require extended Holter monitoring. The wearable biosensor looks for 21 different cardiac arrhythmias by using an artificial intelligence electrocardiogram sensor. It continuously monitors four significant vital signs: heart rate, heart rate variability, respiratory rate and activity.

Tedious And Outdated Holter ECG Analysis

Traditional Holter ECG analysis conducted manually by a cardiologist is complicated and requires a lot of effort. When a Holter examination is carried out, the nurse has to upload the raw signal from the Holter device to a computer, and then the physician creates their report, based on their current knowledge and experience. Thus, the doctor needs to be experienced, precise, and vigilant to be able to prepare such a report correctly.

Segment Analysis

The global ECG Patches and Holter Monitor market is segmented based on device type, application, end-user and region.

The ECG Patches Segment From the Device Type Segment Accounted For Approximately 41.7% of ECG Patches and Holter Monitor Share

The ECG Patches segment from the device type segment accounted for 41.7% and it is expected to be dominated during the forecast period. A wearable ECG patch is equipped with an electrocardiography sensor and accelerometer to detect and record physiological data. Similar to smartwatches, ECG patches can be synced with a device such as a phone or a tablet to display the results.

For instance, in May 2023, VTT Technical Research Centre of Finland developed a new sustainable electrocardiogram (ECG, also known as EKG) patch that is fully recyclable and made of biomaterials. The device is modular, so electronic components can be easily removed from the disposable patch and used again.

The patch itself is made of nanocellulose and printed with carbon conductors and sensing electrodes. The biodegradable patch is made of VTT's new material cellulose e-skin, which replaces traditional plastic in wearable skin applications.

Furthermore, in August 2022 SmartCardia, a leading MedTech company dedicated to strengthening the healthcare ecosystem, launched 7L patch, their 7-lead Cardiac Monitoring Patch in India. This state-of-the-art patch monitor combines medical wearable technology with AI to provide predictive and personalized patient insights through remote monitoring. The 7L patch is tracked by SmartCardia's AI platform which is developed from millions of ECG segments interpreted by cardiologists and certified cardiac technicians and performs real-time detection of important arrhythmia events at cardiologist level accuracy.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the rising incidence of Atrial Fibrillation in the region, ageing population, technological advancements, mergers and acquisitions, shifting patient preference toward ambulatory ECG monitoring, the launch of next-generation wireless ECG monitoring devices, and technological collaborations between manufacturers.

For instance, in January 2021, Boston Scientific announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors - including short and long-term Holter monitors - to cardiac event monitors and mobile cardiac telemetry. The transaction consists of an upfront cash payment of $925 million, and up to an additional $300 million in a potential commercial milestone payment.

Competitive Landscape

The major global players in the market include: Cardinal Health, Ambu, Hillrom (Baxter), Nihon Kohden, Koninklijke Philips N.V., Koninklijke Philips N.V., SCHILLER, GE Healthcare, Henry Schein, Spacelabs Healthcare and among others.

COVID-19 Impact Analysis

COVID-19 has positively impacted the market by increasing the use of ECG patches and Holter monitor devices for diagnosing, evaluating, and treating cardiac conditions. Patients with rhythm monitoring therapy are at a higher risk of developing severe diseases, leading to increased demand and growth in the market.

Also, the COVID-19 pandemic has resulted in high burden on public health and healthcare delivery globally. The disease has major effects on the cardiovascular system. A wide range of arrhythmias have been reported in patients, which complicate the course of COVID-19 due to the associated treatments.

Key Developments

  • In May 2023 Vivalink, a leading provider of digital healthcare solutions, stated the newest version of its multi-parameter wearable electrocardiogram (ECG) patch with continuous 14-day live stream capabilities. With Vivalink's new patch, extended duration remote ECG monitoring can be performed with a single application of the patch, thereby reducing both clinician and patient burden. In addition, the real-time streaming capabilities let clinicians remotely view a patient's live ECG anywhere anytime.
  • In October 2022 Dozee, a healthcare startup that provides contactless remote patient- monitoring launched an easy-to-use ambulatory electrocardiogram (ECG) patch to monitor patients with cardiovascular disease (CVD). This ECG patch is to augment and play a key role in assisting health care professionals (HCPs) in identifying early signs of cardiac deterioration ensuring there is timely medical intervention, thereby improving patient safety.
  • In April 2022 B-Secur stated the launch of the FDA-cleared next-generation ECG cloud-based platform for use across Holter monitors, wearables and implantable devices. According to a company press release, the cloud-based software (Heart Key 2.0) reduces ECG signal noise, improving ECG interpretation for clinicians and facilitating the trend towards remote cardiac monitoring.

Why Purchase the Report?

  • To visualize the global ECG Patches and Holter Monitor market segmentation based on device type, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global ECG Patches and Holter Monitor market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global ECG patches and Holter monitor market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Atrial Fibrillation
      • 4.1.1.2. Rise in the Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Tedious And Outdated Holter ECG Analysis
    • 4.1.3. Opportunity
      • 4.1.3.1. Rise in the Product Launches in Emerging Markets
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. ECG Patches*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Holter Monitor

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Monitoring *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Diagnostics

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Cardinal Health*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Ambu
  • 12.3. Hillrom (Baxter)
  • 12.4. Nihon Kohden
  • 12.5. Koninklijke Philips N.V.
  • 12.6. Koninklijke Philips N.V.
  • 12.7. SCHILLER
  • 12.8. GE Healthcare
  • 12.9. Henry Schein
  • 12.10. Spacelabs Healthcare

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us